Barak Ben-Eliezer
Co-Founder & Managing Partner @ Deep Insight
Israel
Barak Ben-Eliezer is a Co-Founder & Managing Partner at Deep Insight.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Barak Ben-Eliezer invests in
Stages Barak Ben-Eliezer invests in
Countries Barak Ben-Eliezer invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 4 (50%)
- Health Care 3 (38%)
- Biotechnology 2 (25%)
- Medical Device 2 (25%)
- Apps 1 (13%)
Stage
- Series B 3 (38%)
- Series A 2 (25%)
- Series C 1 (13%)
- Funding Round 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- Israel 5 (63%)
- United States 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. UltraSight won the TCT 2020Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics world conference. For mor information please visit us at www.ultrasight.com | $24M / Series B / Sep 23, 2026 | ||
| Greeneye utilizes Artificial Intelligence to disrupt the agricultural pest control process, transitioning from the current practice of broadcast and wasteful spraying to precise and selective spraying of herbicides. Greeneye developed a proprietary selective spraying (SPP) system that turns every sprayer into a smart machine with seamlessintegration, Greeneye’s SSP system can detect weeds and spray them precisely in real-time, reducing up to 90% of herbicide usage. Demo - https://www.youtube.com/watch?v=iCOuTemX_cc&feature=youtu.beGreeneye is a leading technology company with a focus in precision agriculture, established in 2017 and based in Tel-Aviv, Israel. Greeneye has a multidisciplinary team with expertise in computer vision, artificial intelligence, agronomy, mechanical engineering, spraying applications, etc. We work with an extraordinary group of talented and visionary people who are committed to provide sustainable solutions for farmers around the world. | $20M / Venture - Series Unknown / Apr 17, 2024 | ||
| Ramon.Space builds space-resilient super-computer systems that bring cloud computing to space. The New Space market is driven by privatization and commercial goals that give birth to new space services and applications. The demand for significant processing power, storage and better intelligence creates a huge market potential. Yet, the scale ofcomputing capabilities required for New Space applications is not available today due to environmental challenges such as radiation and extreme temperatures. Powered by its unique AI/ML processors, Ramon.space’s software-defined systems enable the realizations of earth-like computing capabilities in space. The company's proven technology is already deployed in space, and is used in many satellites and in more than 50 space missions across the solar system - with zero failures. With its innovative technology and an enthusiastic team that constantly pushes the boundaries of technology, Ramon.Space is set to lead the digital transformation of space. | $26M / Series B / Jun 28, 2023 | ||
| Biond Biologics is a discovery and development company in the prosperous and evolving field of cancer immunotherapy and autoimmune disorders. Biond aims to translate high quality science into breakthrough therapies that will address unmet medical needs while focusing on innovative drugs. Biond is an Israeli company located at Galilee region,combining excellent science and out of the box innovation. | $15M / Series C / Nov 03, 2021 | ||
| Ramon.Space builds space-resilient super-computer systems that bring cloud computing to space. The New Space market is driven by privatization and commercial goals that give birth to new space services and applications. The demand for significant processing power, storage and better intelligence creates a huge market potential. Yet, the scale ofcomputing capabilities required for New Space applications is not available today due to environmental challenges such as radiation and extreme temperatures. Powered by its unique AI/ML processors, Ramon.space’s software-defined systems enable the realizations of earth-like computing capabilities in space. The company's proven technology is already deployed in space, and is used in many satellites and in more than 50 space missions across the solar system - with zero failures. With its innovative technology and an enthusiastic team that constantly pushes the boundaries of technology, Ramon.Space is set to lead the digital transformation of space. | $17.5M / Series A / May 25, 2021 | ||
| their mission is to develop safe and effective neurovascular medical devices that are beneficial to patients and meet physicians' needs. They are committed to advancing patient care by providing the most reliable, easiest to use and highest quality products supported by proven clinical data. Rapid Medical is located at the northern part ofIsrael between the Carmel Mountain and the hills of Ramot Menashe. | $9M / Series B / Jul 17, 2017 | ||
| NowForce is a leader in on-demand emergency response mobile applications, transforming standard mobile phones into life-saving networks. NowForce’s user friendly and cost-effective solutions ensure optimum quality and rapid response for every type of agency regardless of size or scope, including EMS, fire, military, police, security, and volunteerorganizations. With its state-of-the-art SaaS (software-as-a-service) model plugging into responders’ existing GPS-enabled mobile phones, responders––whether in-vehicle, on-foot or off-duty––are always connected to their network. | $4M / Series A / Jan 30, 2012 | ||
| See all 8 investments → | |||
Co-Investors
About Deep Insight
Deep Insight is the first Israeli venture fund to invest only in Deep Tech at all stages and across all sectors, including semiconductors and any scientific or technological breakthrough in physics or life science.
Deep Insight Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Eyal Kishon
Managing Partner
|
|||
|
Barak Ben-Eliezer
Co-Founder & Managing Partner
|
|||
Tal Shahar
Principal
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Barak Ben-Eliezer invest in?
Barak Ben-Eliezer invests primarily in Software, Health Care and Biotechnology startups, most often at Series B and Series A stage. Most of the 8 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Barak Ben-Eliezer?
Public channels for Barak Ben-Eliezer include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Barak Ben-Eliezer last invest?
The most recent investment recorded for Barak Ben-Eliezer closed in Sep 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
